Liberis partners with DNA Payments for merchant funding
By Gloria Methri
In a continued expansion within the SME market, embedded finance provider, Liberis, has announced that it will collaborate with DNA Payments. Under the partnership, Liberis will be analysing data from DNA Payments to offer pre-approved funding to over 65,000 of their merchant customers in the UK and Europe.
DNA Payments provide customer and payment experiences to businesses, helping them receive payments online or via card terminals. Looking to support its SME customer base of 65,000, and growing, it sought to work with Liberis to provide embedded finance solutions as an additional service to its customers.
Lloyd Hutchinson, CCO at DNA Payments said, “We wanted to increase the lifetime value that we can offer our customers, and the next step was to support them with their funding needs. With a trusted provider such as Liberis leading this expansion to our services, we can take away the confusion that our customers face when looking for reputable, reliable, and efficient funding options.”
The partnership will see integrated payment and lending options offered as an additional service within the payments platform. Moreover, the customer data will be optimised and analysed by Liberis to offer personalised funding options. These solutions will be white-labelled within the platform and will help customers access funding sources that they trust and recognise.
Pedram Tadayon, CCO of Liberis said, “We are incredibly proud to be offering our embedded finance services to DNA Payments, one of the UK’s fastest-growing payment providers. Their dedication to their customers, a majority of whom are small business owners, is something that we are passionate about at Liberis – so the partnership is a perfect match.”
IBSi Daily News Analysis
January 16, 2024
Dna Payments
Egypt among top remittance recipient countries in 2023: World Bank
Read MoreIBSi FinTech Journal
- Most trusted FinTech journal since 1991
- Digital monthly issue
- 60+ pages of research, analysis, interviews, opinions, and rankings
- Global coverage